Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rambam Health Care Campus, Haifa, Israel.
Acta Paediatr. 2018 Dec;107(12):2179-2184. doi: 10.1111/apa.14418. Epub 2018 Jun 25.
This study assessed the validity of using established Japanese risk scoring methods to predict intravenous immunoglobulin (IVIG) resistance to Kawasaki disease in Israeli children.
We reviewed the medical records of 282 patients (70% male) with Kawasaki disease from six Israeli medical centres between 2004 and 2013. Their mean age was 2.5 years. The risk scores were calculated using the Kobayashi, Sano and Egami scoring methods and analysed to determine whether a higher risk score predicted IVIG resistance in this population. Factors that predicted a lack of response to the initial IVIG dose were identified.
We found that 18% did not respond to the first IVIG dose. The three scoring methods were unable to reliably predict IVIG resistance, with sensitivities of 23%-32% and specificities of 67%-87%. Calculating a predictive score that was specific for this population was also unsuccessful. The factors that predicted a lacked of response to the first IVIG dose included low albumin, elevated total bilirubin and ethnicity.
The established risk scoring methods created for Japanese populations with Kawasaki disease were not suitable for predicting IVIG resistance in Caucasian Israeli children, and we were unable to create a specific scoring method that was able to do this.
本研究评估了使用已建立的日本风险评分方法预测川崎病以色列儿童静脉注射免疫球蛋白(IVIG)耐药的有效性。
我们回顾了 2004 年至 2013 年间以色列六个医疗中心 282 例(70%为男性)川崎病患儿的病历。他们的平均年龄为 2.5 岁。使用小林、佐野和江成评分方法计算风险评分,并分析其是否可以预测该人群对 IVIG 的耐药性。确定了预测初始 IVIG 剂量无反应的因素。
我们发现,18%的患儿对首次 IVIG 剂量无反应。三种评分方法均不能可靠地预测 IVIG 耐药性,其敏感性为 23%-32%,特异性为 67%-87%。为该人群专门计算预测评分也不成功。预测首次 IVIG 剂量无反应的因素包括低白蛋白、总胆红素升高和种族。
为日本川崎病人群创建的既定风险评分方法不适用于预测白种以色列儿童对 IVIG 的耐药性,我们也无法创建能够做到这一点的特定评分方法。